Molecular Cancer Research Holland AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on July 2, 2007
[Molecular Cancer Research, 10.1158/1541-7786.MCR-07-0032]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow All Versions of this Article:
1541-7786.MCR-07-0032v1
5/7/737    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacManus, C. F.
Right arrow Articles by Waugh, D. J.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacManus, C. F.
Right arrow Articles by Waugh, D. J.J.


Signaling and Regulation

Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells

Christopher F. MacManus , Johanna Pettigrew , Angela Seaton , Catherine Wilson , Pamela J. Maxwell , Silvia Berlingeri , Colin Purcell , Maryalice McGurk , Patrick G. Johnston , and David J.J. Waugh *

Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast City Hospital, Belfast, Northern Ireland

* To whom correspondence should be addressed. E-mail: d.waugh{at}qub.ac.uk.


   Abstract

We have shown previously that interleukin-8 (IL-8) and IL-8 receptor expression is elevated in tumor cells of human prostate biopsy tissue and correlates with increased cyclin D1 expression. Using PC3 and DU145 cell lines, we sought to determine whether IL-8 signaling regulated cyclin D1 expression in androgen-independent prostate cancer (AIPC) cells and to characterize the signaling pathways underpinning this response and that of IL-8-promoted proliferation. Administration of recombinant human IL-8 induced a rapid, time-dependent increase in cyclin D1 expression in AIPC cells, a response attenuated by the translation inhibitor cycloheximide but not by the RNA synthesis inhibitor, actinomycin D. Suppression of endogenous IL-8 signaling using neutralizing antibodies to IL-8 or its receptors also attenuated basal cyclin D1 expression in AIPC cells. Immunoblotting using phospho-specific antibodies confirmed that recombinant human IL-8 induced rapid time-dependent phosphorylation of Akt and the mammalian target of rapamycin substrate proteins, 4E-BP1 and ribosomal S6 kinase, resulting in a downstream phosphorylation of the ribosomal S6 protein (rS6). LY294002 and rapamycin each abrogated the IL-8-promoted phosphorylation of rS6 and attenuated the rate of AIPC cell proliferation. Our results indicate that IL-8 signaling (a) regulates cyclin D1 expression at the level of translation, (b) regulates the activation of proteins associated with the translation of capped and 5'-oligopyrimidine tract transcripts, and (c) activates signal transduction pathways underpinning AIPC cell proliferation. This study provides a molecular basis to support the correlation of IL-8 expression with that of cyclin D1 in human prostate cancer and suggests a mechanism by which this chemokine promotes cell proliferation. (Mol Cancer Res 2007;5(7):737-48)

Key Words: Interleukin-8 (IL-8), Prostate Cancer, Cyclin D1, Proliferation




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. Wilson, C. Purcell, A. Seaton, O. Oladipo, P. J. Maxwell, J. M. O'Sullivan, R. H. Wilson, P. G. Johnston, and D. J. J. Waugh
Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-{kappa}B Transcription and Evasion of Apoptosis
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 746 - 759.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. J.J. Waugh and C. Wilson
The Interleukin-8 Pathway in Cancer
Clin. Cancer Res., November 1, 2008; 14(21): 6735 - 6741.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Wilson, T. Wilson, P. G. Johnston, D. B. Longley, and D. J.J. Waugh
Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells
Mol. Cancer Ther., September 1, 2008; 7(9): 2649 - 2661.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. T. Murooka, R. Rahbar, L. C. Platanias, and E. N. Fish
CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1
Blood, May 15, 2008; 111(10): 4892 - 4901.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.